Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Dec 1;531(2):467-71.
doi: 10.1016/j.gene.2013.08.096. Epub 2013 Sep 10.

A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy

Affiliations
Case Reports

A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy

Atsushi Ishii et al. Gene. .

Abstract

We performed analysis of KCNT1 in two unrelated patients with malignant migrating partial seizures in infancy. Both patients had intractable focal seizures since two months of age. Their seizures were characterized by a shift of epileptic focus during a single seizure and were resistant to most antiepileptic drugs but responded to vagus nerve stimulation in one and clorazepate in the other. Bidirectional sequencing for KCNT1 was analyzed by standard Sanger sequencing method. A de novo c.862G>A (p.Gly288Ser) missense mutation was identified at the pore region of KCNT1 channel in both patients, whereas all KCNT1 mutations in the previous reports were identified mostly in the intracellular C-terminal region. Computational analysis suggested possible changes in the molecular structure and the ion channel property induced by the Gly288Ser mutation. Because the G-to-A transition was located at CG dinucleotide sequences as previously reported for KCNT1 mutations, the recurrent occurrence of de novo KCNT1 mutations indicated the hot spots of these locations.

Keywords: ADNFLE; CLZ; Clorazepate; Hot spot; KCNT1; MMPSI; MOE; Malignant migrating partial seizures in infancy; Molecular operating environment; Vagus nerve stimulation; autosomal dominant nocturnal frontal lobe epilepsy; clorazepate; malignant migrating partial seizures in infancy; molecular operating environment.

PubMed Disclaimer

Publication types

Substances

LinkOut - more resources